Siemens syngo.PET Amyloid Plaque software cleared by FDA

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

The FDA has cleared Siemens Healthcare’s syngo.PET Amyloid Plaque proprietary software and it is now available for use with PET and PET/CT systems.

Designed to assist physicians with assessment of beta amyloid uptake ratios in PET scans of patients being evaluated for Alzheimer’s disease, the software registers PET amyloid images against a reference model of a PET amyloid brain to target regions of interest. Quantification of amyloid-PET images with standardized uptake value ratios could provide information in patients with possible mild cognitive impairment that is useful in supporting visual reads of amyloid-PET images, according to Siemens.